HLA-B*0801-binding EBV peptide
HLA-B*0801-binding EBV peptide is an Epstein-Barr virus (EBV) epitope FLRGRAYGL. HLA-B*0801-binding EBV peptide can bind to the HLA-B*0801 molecule. HLA-B*0801-binding EBV peptide can be presented to CD8+ T cells through HLA-B*0801 to activate a specific immune response.
For research use only. We do not sell to patients.
- CAS No.: 139143-28-5
- Formula: C49H77N15O11
- Molecular Weight:1052.23
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Chemical Information
-
CAS No. 139143-28-5
-
Molecular Weight 1052.23
-
Formula C49H77N15O11
-
Sequence
Phe-Leu-Arg-Gly-Arg-Ala-Tyr-Gly-Leu
-
Sequence Shortening
FLRGRAYGL
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Ely LK, et al. Antagonism of antiviral and allogeneic activity of a human public CTL clonotype by a single altered peptide ligand: implications for allograft rejection. J Immunol. 2005 May 1;174(9):5593-601. [Content Brief]
[2]. Burrows SR, et al. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. J Exp Med. 1995 Dec 1;182(6):1703-15. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)